Testing effectiveness (Phase 2)Ended earlyNCT00098527
What this trial is testing
FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the StomachRecurrent Esophageal Cancer+1 more
National Cancer Institute (NCI) 20